Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile | NEJM


Original Article from The New England Journal of Medicine — Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile

Fonte: Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile | NEJM

Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia | NEJM

Original Article from The New England Journal of Medicine — Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia

Fonte: Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia | NEJM

 

A integra do artigo da NEJM do post anterior

Another JAK Inhibitor Shows Mortality Benefit in COVID-19 | MedPage Today

Tofacitinib cut incidence of severe outcomes in a population where most received steroids

Fonte: Another JAK Inhibitor Shows Mortality Benefit in COVID-19 | MedPage Today

Neurologic Disease after Yellow Fever Vaccination, São Paulo, Brazil, 2017–2018 – Volume 27, Number 6—June 2021 – Emerging Infectious Diseases journal – CDC

Disease should be diagnosed by using the Brighton Collaboration case definitions and cerebrospinal fluid IgM reactivity.

Fonte: Neurologic Disease after Yellow Fever Vaccination, São Paulo, Brazil, 2017–2018 – Volume 27, Number 6—June 2021 – Emerging Infectious Diseases journal – CDC

Publicação com a participação do nosso contemporâneo de residência, Dr. Augusto Penalva

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination | NEJM


Original Article from The New England Journal of Medicine — Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

Fonte: Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination | NEJM

Síndrome pós-aguda por Covid-19


https://www.nature.com/articles/s41591-021-01283-z.pdf?fbclid=IwAR3RjmPqJ_E4nN23TBb5phDlASXwHE4EbpwuMEKob3mACxcGHgyt5Yy-otU

Artigo da nature.
Síndrome pós-aguda COVID-19
Uma revisão abrangente da literatura atual sobre COVID-19 pós-aguda, a sua patofisiologia e as suas sequelas específicas para os órgãos.

Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives

Fonte: Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives

Nature: SARS-CoV-2 receptor is co-expressed with elements of the kinin–kallikrein, renin–angiotensin and coagulation systems in alveolar cells

SARS-CoV-2, the pathogenic agent of COVID-19, employs angiotensin converting enzyme-2 (ACE2) as its cell entry receptor. Clinical data reveal that in severe COVID-19, SARS-CoV-2 infects the lung, leading to a frequently lethal triad of respiratory insufficiency, acute cardiovascular failure, and coagulopathy.

Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients | European Respiratory Society

Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients | European Respiratory Society
— Ler em erj.ersjournals.com/content/56/4/2001811

Association Between Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19


This meta-analysis pools data from 7 randomized trials to estimate the association between administration of corticosteroids vs usual care or placebo and all-cause mortality at 28 days in patients with severe coronavirus disease 2019 (COVID-19).

Fonte: Association Between Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19